Steadman D. Harrison

1.1k total citations
53 papers, 888 citations indexed

About

Steadman D. Harrison is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Steadman D. Harrison has authored 53 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Steadman D. Harrison's work include Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (6 papers) and DNA Repair Mechanisms (4 papers). Steadman D. Harrison is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (6 papers) and DNA Repair Mechanisms (4 papers). Steadman D. Harrison collaborates with scholars based in United States, Malaysia and Germany. Steadman D. Harrison's co-authors include Daniel P. Griswold, Jacqueline Plowman, Donald J. Dykes, William R. Waud, Clifford Sachs, Robert L. Fine, Ahmad R. Safa, Alvin M. Malkinson, David Siegel and Paul A. Bunn and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Steadman D. Harrison

51 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steadman D. Harrison United States 15 543 242 156 118 72 53 888
Siddhartha Kar United States 21 766 1.4× 241 1.0× 146 0.9× 142 1.2× 128 1.8× 41 1.3k
Mikihiko Naito Japan 13 533 1.0× 418 1.7× 61 0.4× 68 0.6× 57 0.8× 18 913
Qiangrong Pan China 13 689 1.3× 203 0.8× 119 0.8× 116 1.0× 193 2.7× 16 967
Nicole Wattez France 14 461 0.8× 143 0.6× 282 1.8× 69 0.6× 65 0.9× 19 900
Jason Nowak United States 15 557 1.0× 165 0.7× 122 0.8× 60 0.5× 95 1.3× 20 1.1k
Ki Deok Shin South Korea 7 404 0.7× 186 0.8× 142 0.9× 48 0.4× 64 0.9× 7 711
Kwang‐Hoe Chung South Korea 20 433 0.8× 87 0.4× 116 0.7× 83 0.7× 77 1.1× 36 963
Fatemeh Karami‐Tehrani Iran 20 648 1.2× 205 0.8× 121 0.8× 74 0.6× 151 2.1× 27 1.1k
Donna L. Dehn United States 13 714 1.3× 145 0.6× 207 1.3× 332 2.8× 89 1.2× 17 1.1k
Maria Meli Italy 12 421 0.8× 182 0.8× 288 1.8× 43 0.4× 59 0.8× 34 839

Countries citing papers authored by Steadman D. Harrison

Since Specialization
Citations

This map shows the geographic impact of Steadman D. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steadman D. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steadman D. Harrison more than expected).

Fields of papers citing papers by Steadman D. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steadman D. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steadman D. Harrison. The network helps show where Steadman D. Harrison may publish in the future.

Co-authorship network of co-authors of Steadman D. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Steadman D. Harrison. A scholar is included among the top collaborators of Steadman D. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steadman D. Harrison. Steadman D. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roix, Jeffrey J., et al.. (2014). Systematic Repurposing Screening in Xenograft Models Identifies Approved Drugs with Novel Anti-Cancer Activity. PLoS ONE. 9(8). e101708–e101708. 9 indexed citations
2.
Parker, George A., et al.. (2005). Mouse model of docetaxel neurotoxicity. Cancer Research. 65. 984–985. 1 indexed citations
3.
Hu, Yi, Andrew G. Stephen, Jin Cao, et al.. (2001). A very early induction of major vault protein accompanied by increased drug resistance in U‐937 cells. International Journal of Cancer. 97(2). 149–156. 28 indexed citations
4.
Sachs, Clifford, Ahmad R. Safa, Steadman D. Harrison, & Robert L. Fine. (1995). Partial Inhibition of Multidrug Resistance by Safingol Is Independent of Modulation of P-glycoprotein Substrate Activities and Correlated with Inhibition of Protein Kinase C. Journal of Biological Chemistry. 270(44). 26639–26648. 87 indexed citations
5.
Dykes, Donald J., et al.. (1995). Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere®). Investigational New Drugs. 13(1). 1–11. 39 indexed citations
6.
Waud, William R., et al.. (1992). Cross-resistance of drug-resistant murine P388 leukemias to toxol in vivo. Cancer Chemotherapy and Pharmacology. 31(3). 255–257. 11 indexed citations
7.
Waud, William R., Jacqueline Plowman, Steadman D. Harrison, et al.. (1992). Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice. Cancer Chemotherapy and Pharmacology. 30(4). 261–266. 4 indexed citations
8.
Waud, William R., Steadman D. Harrison, Carroll Temple, & Daniel P. Griswold. (1992). Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7-ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370 147) 370 147. Cancer Chemotherapy and Pharmacology. 29(3). 190–194. 3 indexed citations
9.
Waud, William R., et al.. (1991). Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia. Cancer Chemotherapy and Pharmacology. 27(6). 456–463. 34 indexed citations
10.
Griswold, Daniel P. & Steadman D. Harrison. (1991). Tumor models in drug development. Cancer and Metastasis Reviews. 10(3). 255–261. 5 indexed citations
11.
Harrison, Steadman D., Jacqueline Plowman, Donald J. Dykes, William R. Waud, & Daniel P. Griswold. (1990). Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo. Cancer Chemotherapy and Pharmacology. 25(6). 425–429. 7 indexed citations
12.
Plowman, Jacqueline, Kenneth D. Paull, Ghanem Atassi, et al.. (1988). Preclinical antitumor activity of batracylin (NSC 320846). Investigational New Drugs. 6(3). 147–153. 35 indexed citations
13.
Grem, Jean L., Dale Shoemaker, Daniel F. Hoth, et al.. (1987). Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials. Investigational New Drugs. 5(4). 315–328. 18 indexed citations
14.
Harrison, Steadman D., et al.. (1987). Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo. Investigational New Drugs. 5(4). 345–351. 11 indexed citations
15.
Wilkoff, Lee J., Elizabeth A. Dulmadge, M W Trader, Steadman D. Harrison, & Daniel P. Griswold. (1987). Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II). Cancer Chemotherapy and Pharmacology. 20(2). 96–100. 32 indexed citations
16.
Harrison, Steadman D., Dennis M. Mann, & R. C. Giles. (1985). Effect of nitrosoureas on calmodulin activity in vitro and in mouse intestine in vivo. Cancer Chemotherapy and Pharmacology. 14(2). 146–149. 9 indexed citations
17.
Harrison, Steadman D., et al.. (1979). Hematologic and histopathologic evaluation of N-(phosphonacetyl)-l-aspartate (PALA) in mice. Cancer Chemotherapy and Pharmacology. 2(3). 183–187. 4 indexed citations
18.
Harrison, Steadman D., et al.. (1978). Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(8). 2636–9. 28 indexed citations
19.
Harrison, Steadman D., Talmage R. Bosin, & Roger P. Maickel. (1974). Metabolism of 3-(2-dimethylaminoethyl)benzo(b)thiophene in vitro and in vivo in the rat.. PubMed. 2(3). 228–36. 4 indexed citations
20.
Carmack, Marvin, Charles J. Kelley, Steadman D. Harrison, & Kenneth P. DuBois. (1972). Optically active dithiothreitol. Toxicity and radiation-protective activity. Journal of Medicinal Chemistry. 15(6). 600–603. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siddhartha Kar Breakdown of academic impact, for papers by Mikihiko Naito Breakdown of academic impact, for papers by Qiangrong Pan Breakdown of academic impact, for papers by Nicole Wattez Breakdown of academic impact, for papers by Jason Nowak Breakdown of academic impact, for papers by Ki Deok Shin Breakdown of academic impact, for papers by Kwang‐Hoe Chung Breakdown of academic impact, for papers by Fatemeh Karami‐Tehrani Breakdown of academic impact, for papers by Donna L. Dehn Breakdown of academic impact, for papers by Maria Meli
Rankless by CCL
2026